1. P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma
    Caterina Costa et al, 2020, Cell Death & Disease CrossRef
  2. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients
    Wenjun Liu et al, 2018, Cancer Biomarkers CrossRef
  3. Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs
    Helena Kelly et al, 2015, PLOS ONE CrossRef
  4. High Expression Levels of miR-21 and miR-210 Predict Unfavorable Survival in Breast Cancer: A Systemic Review and Meta-Analysis
    Yiting Tang et al, 2015, The International Journal of Biological Markers CrossRef
  5. Overview of MicroRNA Expression in Predicting Response to Neoadjuvant Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer – A Systematic Review
    Matthew G Davey et al, 2022, Breast Cancer: Basic and Clinical Research CrossRef
  6. Regulatory network analysis of high expressed long non-coding RNA LINC00941 in gastric cancer
    Cong Luo et al, 2018, Gene CrossRef
  7. MicroRNA-320a inhibition decreases insulin-induced KGN cell proliferation and apoptosis by targeting PCGF1
    Lei Yang et al, 2017, Molecular Medicine Reports CrossRef
  8. miR-320a serves as a negative regulator in the progression of gastric cancer by targeting RAB14
    Yongyuan Li et al, 2017, Molecular Medicine Reports CrossRef
  9. Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas
    Jeremy T-H. Chang et al, 2016, PLOS ONE CrossRef
  10. Downregulation of miR‑505 promotes cell proliferation, migration and invasion, and predicts poor prognosis in breast cancer
    Jian Wang et al, 2019, Oncology Letters CrossRef
  11. Extracellular vesicle-derived miR-320a targets ZC3H12B to inhibit tumorigenesis, invasion, and angiogenesis in ovarian cancer
    Yan Huang et al, 2021, Discover Oncology CrossRef
  12. Specific miRNA expression profile in the blood serum of cardiac myxoma patients
    Liangliang Yan et al, 2018, Oncology Letters CrossRef
  13. CREB1-driven expression of miR-320a promotes mitophagy by down-regulating VDAC1 expression during serum starvation in cervical cancer cells
    Qin-qin Li et al, 2015, Oncotarget CrossRef
  14. MicroRNAs miR-142-5p, miR-150-5p, miR-320a-3p, and miR-4433b-5p in Serum and Tissue: Potential Biomarkers in Sporadic Breast Cancer
    Tamyres Mingorance Carvalho et al, 2022, Frontiers in Genetics CrossRef
  15. MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor
    Jianguo Wang et al, 2017, Oncology Letters CrossRef
  16. miR-29b is an indicator of prognosis in breast cancer patients
    YOSHIAKI SHINDEN et al, 2015, Molecular and Clinical Oncology CrossRef
  17. USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells
    Ying Zhu et al, 2017, Oncotarget CrossRef
  18. Prognostic role of microRNAs in breast cancer: A systematic review
    Eleni Zografos et al, 2019, Oncotarget CrossRef
  19. MicroRNA-320 targets mitogen-activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer
    Yongqian Xu et al, 2017, Molecular Medicine Reports CrossRef
  20. MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin
    Juan Yu et al, 2016, Oncotarget CrossRef
  21. MicroRNA: A Signature for Cancer Diagnostics
    Ayesha Siddiqua et al, 2020, Current Cancer Treatment CrossRef
  22. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway
    Wen Zhao et al, 2018, Gene CrossRef
  23. Regulatory role of microRNA‐320a in the proliferation, migration, invasion, and apoptosis of trophoblasts and endothelial cells by targeting estrogen‐related receptor γ
    Rong‐Hua Liu et al, 2019, Journal of Cellular Physiology CrossRef
  24. Decreased serum exosomal miR-320a expression is an unfavorable prognostic factor in patients with hepatocellular carcinoma
    Xinjie Hao et al, 2020, Journal of International Medical Research CrossRef
  25. Relationship between the microRNAs and PI3K/AKT/mTOR axis: Focus on non-small cell lung cancer
    Yi Lin et al, 2022, Pathology - Research and Practice CrossRef
  26. Absolute quantification of lung cancer related microRNA by droplet digital PCR
    Ping Wang et al, 2015, Biosensors and Bioelectronics CrossRef
  27. MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy
    Yuanyuan Liang et al, 2021, Biomedicines CrossRef